ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
28 hedge funds and large institutions have $621K invested in Anthera Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
90% less capital invested
Capital invested by funds: $6.37M → $621K (-$5.74M)
Holders
28
Holding in Top 10
–
Calls
$452K
Puts
$14K
Top Buyers
| 1 | +$132K | |
| 2 | +$129K | |
| 3 | +$46.6K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.9K |
| 5 |
Goldman Sachs
New York
|
+$37K |
Top Sellers
| 1 | -$2.01M | |
| 2 | -$1.29M | |
| 3 | -$1.27M | |
| 4 |
6CM
683 Capital Management
New York
|
-$399K |
| 5 |
Millennium Management
New York
|
-$111K |